Daiichi Sankyo's Enhertu Wins EU Approval for Early Breast Cancer Treatment
The EU approved Enhertu for adjuvant treatment of early breast cancer.
Story updates
07:32:04 AM UTC
SquawkNews
UE aprueba Enhertu de Daiichi Sankyo como tratamiento adyuvante para cáncer de mama HER2 positivo